Lifestyle Changes for Prediabetes
Trial Summary
Will I have to stop taking my current medications?
The trial excludes participants who are on medications that affect insulin sensitivity, glucose concentrations, and body weight, so you may need to stop taking such medications to participate.
What data supports the effectiveness of the treatment for prediabetes?
Research shows that maintaining a consistent sleep pattern and making lifestyle changes can help control blood sugar levels in people with prediabetes. Studies have found that irregular sleep and short sleep duration are linked to a higher risk of developing diabetes, while structured lifestyle interventions can improve glucose metabolism.12345
Is the lifestyle intervention for prediabetes safe for humans?
The studies suggest that lifestyle interventions, including those focusing on sleep and consistent daily routines, are generally safe for humans. These interventions have been tested in various groups, including people with prediabetes and those living with HIV, without significant safety concerns reported.13467
How is the Fixed Schedule, Fixed Sleep treatment for prediabetes different from other treatments?
This treatment focuses on maintaining a consistent sleep schedule, which is unique because irregular sleep is linked to poor glucose metabolism. Unlike other treatments that may focus solely on diet and exercise, this approach emphasizes stable sleep patterns as a key component of managing prediabetes.35789
What is the purpose of this trial?
The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes.The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.
Research Team
Blandine Laferrere
Principal Investigator
Columbia University
Marie-Pierre St-Onge
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for adults aged 35 or older with prediabetes, defined by specific blood sugar levels (hemoglobin A1c between 5.7-6.4%). Participants should have a BMI of 25-39.9 and sleep at least 6 hours nightly. Excluded are those with cardiovascular disease, certain kidney conditions, sleep apnea, recent weight loss programs, severe lipid problems, shift workers, substance abuse history, uncontrolled high blood pressure or psychiatric disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants track their sleep and wear a glucose monitor to measure glucose levels
Treatment
Participants are randomized to either maintain usual habits or stabilize lifestyle behaviors
Follow-up
Participants are monitored for changes in glucose control, body composition, and liver fat
Treatment Details
Interventions
- Fixed Schedule
- Fixed Sleep
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Department of Health and Human Services
Collaborator